REPORT ID 2346

United States OTC Drug Market Report 2017

Publish Date
8-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the United States OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of OTC Drug in these regions, from 2012 to 2022 (forecast).

United States OTC Drug market competition by top manufacturers/players, with OTC Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer HealthCare
    GlaxoSmithKline (GSK)
    Johnson&Johnson
    Pfizer
    Sanofi
    AstraZeneca
    BioGaia
    Bristol Myers Squibb
    Bukwang Pharmaceutica
    Chr. Hansen
    Cipla
    CoLucid
    Daiichi Sankyo
    Friggs
    DSM
    Eisai
    Eli Lilly
    Herbalife
    Euradite

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Class A
    Class B
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Household

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States OTC Drug Market Report 2017
1 OTC Drug Overview
    1.1 Product Overview and Scope of OTC Drug
    1.2 Classification of OTC Drug by Product Category
        1.2.1 United States OTC Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States OTC Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Class A
        1.2.4 Class B
    1.3 United States OTC Drug Market by Application/End Users
        1.3.1 United States OTC Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Household
    1.4 United States OTC Drug Market by Region
        1.4.1 United States OTC Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West OTC Drug Status and Prospect (2012-2022)
        1.4.3 Southwest OTC Drug Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic OTC Drug Status and Prospect (2012-2022)
        1.4.5 New England OTC Drug Status and Prospect (2012-2022)
        1.4.6 The South OTC Drug Status and Prospect (2012-2022)
        1.4.7 The Midwest OTC Drug Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of OTC Drug (2012-2022)
        1.5.1 United States OTC Drug Sales and Growth Rate (2012-2022)
        1.5.2 United States OTC Drug Revenue and Growth Rate (2012-2022)

2 United States OTC Drug Market Competition by Players/Suppliers
    2.1 United States OTC Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States OTC Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States OTC Drug Average Price by Players/Suppliers (2012-2017)
    2.4 United States OTC Drug Market Competitive Situation and Trends
        2.4.1 United States OTC Drug Market Concentration Rate
        2.4.2 United States OTC Drug Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers OTC Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States OTC Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States OTC Drug Sales and Market Share by Region (2012-2017)
    3.2 United States OTC Drug Revenue and Market Share by Region (2012-2017)
    3.3 United States OTC Drug Price by Region (2012-2017)

4 United States OTC Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States OTC Drug Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States OTC Drug Revenue and Market Share by Type (2012-2017)
    4.3 United States OTC Drug Price by Type (2012-2017)
    4.4 United States OTC Drug Sales Growth Rate by Type (2012-2017)

5 United States OTC Drug Sales (Volume) by Application (2012-2017)
    5.1 United States OTC Drug Sales and Market Share by Application (2012-2017)
    5.2 United States OTC Drug Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States OTC Drug Players/Suppliers Profiles and Sales Data
    6.1 Bayer HealthCare
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 OTC Drug Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GlaxoSmithKline (GSK)
        6.2.2 OTC Drug Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson&Johnson
        6.3.2 OTC Drug Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 OTC Drug Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi
        6.5.2 OTC Drug Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.2 OTC Drug Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 BioGaia
        6.7.2 OTC Drug Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Bristol Myers Squibb
        6.8.2 OTC Drug Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Bukwang Pharmaceutica
        6.9.2 OTC Drug Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Chr. Hansen
        6.10.2 OTC Drug Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Cipla
    6.12 CoLucid
    6.13 Daiichi Sankyo
    6.14 Friggs
    6.15 DSM
    6.16 Eisai
    6.17 Eli Lilly
    6.18 Herbalife
    6.19 Euradite

7 OTC Drug Manufacturing Cost Analysis
    7.1 OTC Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of OTC Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 OTC Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States OTC Drug Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States OTC Drug Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States OTC Drug Sales Volume Forecast by Type (2017-2022)
    11.3 United States OTC Drug Sales Volume Forecast by Application (2017-2022)
    11.4 United States OTC Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer